Peptide Institute (Japan)

Peptide Institute (Japan) is a company based in Osaka, Japan. According to its official website, it aims to contribute to the science of peptides, carbohydrates and amino acids by providing research reagents and pharmaceuticals, and states it has been trusted by 10,000+ scientists since 1977. Its activities span peptide synthesis, carbohydrate-related synthesis, antibody (polyclonal) production and peptide drug development (GMP), with services covering basic research through commercial production.

The company's history page records that in 1977 Peptide Institute, Inc. was established and Shunpei Sakakibara became its first president. In 1983, all peptide synthesis operations were transferred from the Protein Research Foundation to Peptide Institute, Inc. In 1990 the company obtained a pharmaceutical manufacturing license. In 2006 it established the Saito Laboratory (in Ibaraki City, Saito) including GMP-compliant facilities. In 2018 Masahiko Tsunemi became president. The same page traces earlier origins: in 1959 a Protein Research Foundation (voluntary organization) was set up within the Institute for Protein Research, Osaka University; in 1962 it was reorganized into a foundation under the jurisdiction of the Ministry of Education (now MEXT); in 1963 it began peptide operations; and in 1972 it opened the Peptide Institute in Minoh City.

Aims to contribute to the science of peptides, carbohydrates and amino acids by providing the world's highest quality research reagents and pharmaceuticals.

• Research reagents

• Pharmaceuticals

• Peptides

• Carbohydrate-related compounds

• Antibodies

1. 1株式会社ペプチド研究所 - ペプチド・糖・アミノ酸の化学に貢献peptide.co.jp
2. 2沿革 | 株式会社ペプチド研究所peptide.co.jp
3. 3企業情報 | 株式会社ペプチド研究所peptide.co.jp
4. 4アクセス | 株式会社ペプチド研究所peptide.co.jp
5. 5Peptide Institute (Japan)wikidata.org